572 articles – 406 Notices  [english version]

hal-00723908, version 1

Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI

Hamanou Benachour 1, Aymeric Sève 2, Thierry Bastogne 13, Céline Frochot 24, Régis Vanderesse 5, Jordane Jasniewski 6, Imen Miladi 7, Claire Billotey 7, Olivier Tillement 7, François Lux 7, Muriel Barberi-Heyob 148

Theranostics 2, 9 (2012) 889-904

Résumé : Photodynamic therapy (PDT) is an emerging theranostic modality for various cancer as well as non-cancer diseases. Its efficiency is mainly based on a selective accumulation of PDT and imaging agents in tumor tissue. The vascular effect is widely accepted to play a major role in tumor eradication by PDT. To promote this vascular effect, we previously demonstrated the interest of using an active- targeting strategy targeting neuropilin-1 (NRP-1), mainly over-expressed by tumor angiogenic vessels. For an integrated vascular-targeted PDT with magnetic resonance imaging (MRI) of cancer, we developed multifunctional gadolinium-based nanoparticles consisting of a surface-localized tumor vasculature targeting NRP-1 peptide and polysiloxane nanoparticles with gadolinium chelated by DOTA derivatives on the surface and a chlorin as photosensitizer. The nanoparticles were surface-functionalized with hydrophilic DOTA chelates and also used as a scaffold for the targeting peptide grafting. In vitro investigations demonstrated the ability of multifunctional nanoparticles to preserve the photophysical properties of the encapsulated photosensitizer and to confer photosensitivity to MDA-MB-231 cancer cells related to photosensitizer concentration and light dose. Using binding test, we revealed the ability of peptide-functionalized nanoparticles to target NRP-1 recombinant protein. Importantly, after intravenous injection of the multifunctional nanoparticles in rats bearing intracranial U87 glioblastoma, a positive MRI contrast enhancement was specifically observed in tumor tissue. Real-time MRI analysis revealed the ability of the targeting peptide to confer specific intratumoral retention of the multifunctional nanoparticles.

  • 1 :  Centre de Recherche en Automatique de Nancy (CRAN)
  • CNRS : UMR7039 – Université de Lorraine
  • 2 :  Laboratoire Réactions et Génie des Procédés (LRGP)
  • CNRS : UPR3349
  • 3 :  BIGS (INRIA Nancy - Grand Est / IECN)
  • INRIA – CNRS : UMR7502 – Université de Lorraine
  • 4 :  Médicaments Photoactivables - Photochimiothérapie (PHOTOMED)
  • CNRS : GDR3049 – Institut de Chimie du CNRS
  • 5 :  Laboratoire de chimie-physique macromoléculaire (LCPM)
  • CNRS : UMR7568 – Institut National Polytechnique de Lorraine (INPL)
  • 6 :  Laboratoire d'Ingénierie des Biomolécules (LIBio)
  • Université de Lorraine
  • 7 :  Laboratoire de Physico-Chimie des Matériaux Luminescents (LPCML)
  • CNRS : UMR5620 – Université Claude Bernard - Lyon I
  • 8 :  Centre Alexis Vautrin
  • CRLCC Alexis Vautrin
  • Domaine : Sciences du Vivant/Ingénierie biomédicale
  • Mots-clés : Targeted PDT – neuropilin-1 – brain tumor – MRI – functionalized theranostic nanoparticles
  • Référence interne : IPS, SBS
 
  • hal-00723908, version 1
  • oai:hal.archives-ouvertes.fr:hal-00723908
  • Contributeur : 
  • Soumis le : Mercredi 15 Août 2012, 15:50:28
  • Dernière modification le : Mardi 13 Novembre 2012, 15:38:22